---
title: "Alignment Healthcare EVP Joseph S. Konowiecki sells 25,000 shares worth $600,000"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291460491.md"
description: "Alignment Healthcare EVP Joseph S. Konowiecki sold 25,000 common shares on July 1, 2026, at $24 per share, totaling $600,000. Following the transaction, his holdings stand at 1,103,816 shares."
datetime: "2026-07-01T20:39:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291460491.md)
  - [en](https://longbridge.com/en/news/291460491.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291460491.md)
generator: "portal-rs"
---

# Alignment Healthcare EVP Joseph S. Konowiecki sells 25,000 shares worth $600,000

-   Alignment Healthcare director, EVP Corporate Affairs Joseph S. Konowiecki sold 25,000 common shares on July 1, 2026. \* Sale price USD 24 per share. \* Holdings stood at 1,103,816 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alignment Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-046575), on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ALHC.US](https://longbridge.com/en/quote/ALHC.US.md)

## Related News & Research

- [Alignment Healthcare CEO John E. Kao reports disposal of common shares worth $7.12 million](https://longbridge.com/en/news/298778112.md)
- [Alignment Healthcare CEO John Kao disposes of 298,000 common shares worth $4.14 million](https://longbridge.com/en/news/295457465.md)
- [Singapore Index Fund amends trust deed to add electronic transfers, phase out cheques from Oct. 1, 2026](https://longbridge.com/en/news/298710637.md)
- [Damartex reports FY2025-26 annual results release available](https://longbridge.com/en/news/298344100.md)
- [BioLineRx outlines Phase 1/2a GLIX1 trial in recurrent high-grade glioma at EANO 2026](https://longbridge.com/en/news/298582374.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**